iiinova — where your digital self keeps evolving

FIBROTARGET @fibrotarget.bsky.social · 07/10/2026

🔬Meet FIBROTARGET’s early-career researchers! Postdoctoral researcher Gerlanda Vella is investigating the mechanisms behind intestinal fibrosis in IBD, helping advance research towards future therapies. Read about her work and the role of FIBROTARGET in this interview: ➡️https://loom.ly/n0Le4wY

000

FIBROTARGET @fibrotarget.bsky.social · 24/09/2026

🤔Have you explored the FIBROTARGET Training academy? Learn about: ✅Experimental methods to study intestinal fibrosis ✅In-vivo models for fibrosis induction ✅omics-based techniques 💻Explore the full Training Academy on the FIBROTARGET web➡️: loom.ly/wj313Io #HorizonEurope #IBD

000

FIBROTARGET @fibrotarget.bsky.social · 08/09/2026

💬For Cora Sanches, living with ulcerative colitis has become a starting point for advocacy. In this patient story, the young IFCCA patient advocate from Brazil shares how her personal experience has grown into a commitment to support and empower others. 🎥https://loom.ly/LfDrB7Y

youtube.com

FIBROTARGET Patient Stories: Cora

FIBROTARGET

000

FIBROTARGET @fibrotarget.bsky.social · 27/08/2026

📹 How can we improve outcomes for people living with IBD? In this interview, FIBROTARGET coordinator Gianluca Matteoli discusses earlier diagnosis, better monitoring and the importance of patient involvement. 📹 Watch the full interview & learn more about FIBROTARGET➡️ loom.ly/OljVKGY

000

FIBROTARGET @fibrotarget.bsky.social · 19/08/2026

🔍 What is intestinal fibrosis, and why is it such a major challenge for people living with IBD? Our FIBROTARGET factsheet provides an accessible overview of the condition and the project's work to improve its diagnosis, monitoring and treatment Learn more here➡️ loom.ly/1kbh0bc

000

FIBROTARGET @fibrotarget.bsky.social · 11/08/2026

🎓The FIBROTARGET Training Academy is now fully available, with all modules online! Explore practical training resources covering in vitro, in vivo and ex vivo fibrosis models, as well as omics-based annotation. 📚 🔗 Discover the full Academy and start learning: loom.ly/wj313Io

000

FIBROTARGET @fibrotarget.bsky.social · 23/07/2026

🎥 ICYMI: How does IBD shape life beyond the diagnosis? Noemi Stefanucci, a young IBD advocate from Italy and member of the IFCCA Youth Group, shares her experience of living with Crohn's disease and the impact it has had on her life. Learn more➡️https://loom.ly/yJfqEyE #IBD #DiseaseAwareness

020

FIBROTARGET @fibrotarget.bsky.social · 10/07/2026

📚 Explore FIBROTARGET's growing collection of scientific publications on intestinal fibrosis and fibrostenosis in IBD. 💻Browse the research and read accompanying explainers on our website. loom.ly/Y58Ax5s

000

FIBROTARGET @fibrotarget.bsky.social · 03/07/2026

📚 The full FIBROTARGET #TrainingAcademy is now available! Explore 4 expert-led modules covering in vitro, in vivo and ex vivo fibrosis models, plus omics-based annotation for studying intestinal fibrosis in IBD. 💻 Learn more: loom.ly/wj313Io

000

FIBROTARGET @fibrotarget.bsky.social · 25/06/2026

📚 New: the FIBROTARGET Training Academy – a resource to learn more about intestinal fibrosis in IBD. 3 modules now live, covering key concepts, challenges, and emerging research directions. 💻 Start exploring here: loom.ly/wj313Io

000

FIBROTARGET @fibrotarget.bsky.social · 22/06/2026

🔊This week! FIBROTARGET joins the GENEGUT Cluster Event on RNA therapeutics for IBD (24 June), alongside EU projects, researchers, industry and patient groups to discuss key challenges and strengthen collaboration. Explore the VR exhibition here➡️https://loom.ly/XRPsM #HorizonEurope

010

FIBROTARGET @fibrotarget.bsky.social · 17/06/2026

📸 FIBROTARGET is LIVE at #ECM2026 in Copenhagen! Coordinator Gianluca Matteoli and Bram Verstockt (KU Leuven) are presenting ongoing work in intestinal fibrosis and engaging with the ECM research community. Learn more about the FIBROTARGET project here➡️https://loom.ly/IGYRLgM

000

FIBROTARGET @fibrotarget.bsky.social · 09/06/2026

📚Discover the FIBROTARGET Training Academy: a new resource designed to support learning on intestinal fibrosis in IBD! Three modules are now available, offering insights into key concepts, current challenges, and emerging approaches in fibrosis research. 💻Learn more: loom.ly/wj313Io

000

FIBROTARGET @fibrotarget.bsky.social · 01/06/2026

📹 Why does intestinal fibrosis remain such a major unmet need in IBD? On 3 June, FIBROTARGET’s Bram Verstockt joins the Nordic Bioscience webinar on collagen remodelling and fibrosis looking at current challenges and new clinical insights. Register here➡️ loom.ly/na2rE6A

000

FIBROTARGET @fibrotarget.bsky.social · 27/05/2026

📣 This #WorldIBDDay2026, FIBROTARGET supported the global campaign on access to IBD care, highlighting ongoing gaps in diagnosis, treatment and support. ➡️ Explore FIBROTARGET's contribution here: loom.ly/Y5rDUNA #WorldIBDDay2026 #IBDHasNoBorders #HorizonEU

020

FIBROTARGET @fibrotarget.bsky.social · 19/05/2026

🟣🗺️ Today is #WorldIBDDay IBD Has No Borders. Access to care should not depend on geography. We support IFCCA’s call for equitable, timely IBD care worldwide and highlight the need to prevent complications like fibrosis. Learn more➡️: loom.ly/cVlk6EQ #IBDHasNoBorders

000

FIBROTARGET @fibrotarget.bsky.social · 15/05/2026

#WorldIBDDay highlights the need for timely, equitable care. Early diagnosis in #IBD remains a challenge, affecting progression and outcomes. FIBROTARGET coordinator Gianluca Matteoli explains how research supports earlier detection, better tools and patient involvement. 📹 Watch the interview ⤵️

000

FIBROTARGET @fibrotarget.bsky.social · 07/05/2026

🔍Looking inside the gut: imaging tools to understand IBD fibrosis 🔬New non‑invasive imaging approaches aim to strengthen how fibrosis is detected, helping clinicians make clearer, more consistent decisions. ➡️Learn more and read the full article here: loom.ly/Qxk3wL4 #IBDHasNoBorders

000

FIBROTARGET @fibrotarget.bsky.social · 04/05/2026

📌 ICYMI: FIBROTARGET has released Training Academy – Module 2, focusing on in vivo fibrosis models for IBD research. Practical insights for early‑career researchers working on intestinal fibrosis 🔬 Explore the Training Academy here ➡️ loom.ly/wj313Io

000

FIBROTARGET @fibrotarget.bsky.social · 29/04/2026

🎥 New reel out now! Highlights from the FIBROTARGET GAM 2026 in Barcelona: two days of scientific exchange, multistakeholder perspectives and collaboration. Hear from coordinator Gianluca Matteoli and clinical lead Bram Verstockt for more on progress. Key takeaways➡️ loom.ly/VX7K4iU

001

FIBROTARGET @fibrotarget.bsky.social · 23/04/2026

🚫 Fibrosis is not the same as inflammation, and once it has progressed, it often cannot be reversed. When IBD care is delayed, the risk of fibrosis and surgery increases. ➡️Understanding fibrosis supports earlier, more equitable care. Discover more!⬇️ #WorldIBDDay2026 #IBDHasNoBorders

000

FIBROTARGET @fibrotarget.bsky.social · 15/04/2026

🗺️ #WorldIBDDay2026 (19 May) reminds us: access to IBD care should not depend on geography. In the lead‑up, #FIBROTARGET will focus on intestinal fibrosis - a complication often linked to delayed diagnosis and gaps in care. Discover more➡️https://fibrotarget.eu/ #IBDHasNoBorders #AccessToIBDCare

000

FIBROTARGET @fibrotarget.bsky.social · 13/04/2026

🔬🤝From Clinical Trials to Real Impact: Turning Fibrosis Research into Better Care FIBROTARGET and IFCCA recently hosted a webinar bringing together researchers, clinicians, industry and patient voices to discuss the future of fibrosis care in IBD! 📺Watch the recording: loom.ly/z0gezTw

000

FIBROTARGET @fibrotarget.bsky.social · 09/04/2026

🎓New training resource released: FIBROTARGET Training Academy – Module 2 This new module focuses on in vivo fibrosis models, supporting early‑career researchers working in IBD with practical training on fibrosis induction and monitoring in mice🔬. Discover the Academy!➡️ loom.ly/wj313Io

000

FIBROTARGET @fibrotarget.bsky.social · 02/04/2026

📣 Webinar today - don’t miss it! Join the FIBROTARGET–IFCCA webinar to explore how fibrosis research and patient voices can lead to real improvements in IBD care. 🗓️ Today | 2 April 2026 🕕 18:00–19:00 CEST | 🌐 Online Register now: loom.ly/RuUAO_M #IBD #Fibrosis #PatientVoice

000

FIBROTARGET @fibrotarget.bsky.social · 30/03/2026

📣 This week: FIBROTARGET–IFCCA webinar Living with IBD fibrosis? Join this free online webinar to explore how research and patient voices can lead to real improvements in care and quality of life. 📆 2 Apr • 🌐 Online Register➡️: loom.ly/RuUAO_M #IBD #Fibrosis #PatientVoice

000

FIBROTARGET @fibrotarget.bsky.social · 26/03/2026

🎥In this patient story, Noemi Stefanucci, a young IBD advocate from Italy and member of the IFCCA Youth Group, looks back on how the condition has shaped her life, decisions and career path. Learn more➡️https://loom.ly/yJfqEyE #IBD #DiseaseAwareness

000

FIBROTARGET @fibrotarget.bsky.social · 25/03/2026

⏳ One week to go! How can fibrosis research improve daily life for people living with IBD? Join the FIBROTARGET–IFCCA webinar to explore how patient needs and lived experience can shape better trials and future care. 📆 2 Apr • 🌐 Online • 🕕 18:00–19:00 CEST 👉 Register: loom.ly/Qlznsec

000

FIBROTARGET @fibrotarget.bsky.social · 19/03/2026

🌍👥 FIBROTARGET GAM 2026 is underway in Barcelona! FIBROTARGET partners have gathered in Barcelona for our 4th GAM to present latest updates, discuss current challenges and outline future directions for the project. Stay tuned for more updates soon! 🔗 loom.ly/IGYRLgM

010

FIBROTARGET @fibrotarget.bsky.social · 16/03/2026

⏰Introducing the agenda for the upcoming FIBROTARGET-IFCCA webinar! 🔬From Clinical Trials to Real Impact: The Future of Fibrosis Care 📆 2 Apr 2026 • 🕕 18:00–19:00 CEST • 🌐 Online ➡️ Discover the full agenda below and register here: loom.ly/RuUAO_M

000

FIBROTARGET @fibrotarget.bsky.social · 13/03/2026

🎓Have you explored the FIBROTARGET Training Academy? 🎬 Module 1 explores in vitro fibrosis models using primary fibroblasts and iPSC‑derived systems - supporting early‑career scientists advancing intestinal fibrosis research. 👉 Explore: loom.ly/7tKSj4M

001

FIBROTARGET @fibrotarget.bsky.social · 11/03/2026

🔬WEBINAR: From Clinical Trials to Real Impact: The Future of Fibrosis Care 🌐 Online 📆2 April 2026 🕕18:00-19:00 CEST Join experts + patient voices to explore advances in fibrosis care, imaging & patient‑centred trials. ➡️ Register: loom.ly/RuUAO_M 💻 Learn more: loom.ly/Qlznsec

000

FIBROTARGET @fibrotarget.bsky.social · 27/02/2026

🎓Boost Your Hands‑On Lab Skills: Practical training for IBD Researchers! The FIBROTARGET Training Academy supports early‑career IBD researchers with hands‑on modules across key immunological techniques. 🎬 Module 1: In vitro fibrosis models ➡️ loom.ly/7tKSj4M #IBDResearch #Fibrosis

000

FIBROTARGET @fibrotarget.bsky.social · 20/02/2026

🥼 Curious about the future of fibrosis research in IBD? Meet us at #ECCO2026 to learn how FIBROTARGET is advancing prevention, diagnosis & treatment of intestinal fibrosis. 📍 With IFCCA at Stockholmsmässan, Booth 33, Hall A (until 21 Feb) More ➡️ loom.ly/IGYRLgM

000

FIBROTARGET @fibrotarget.bsky.social · 29/01/2026

🔬🔍 Did you know FIBROTARGET is advancing research to better understand and tackle intestinal fibrosis? The project has 5️⃣ publications on biomarkers, innovative lab techniques, and therapies to better understand and target fibrosis. 📖 Read more: loom.ly/oUyA3DU

000

FIBROTARGET @fibrotarget.bsky.social · 21/01/2026

💭 What’s it like living with fibrosis? Last year, we spoke to Anastasia Ntanou, an IBD advocate from Greece, about her 15+ years living with fibrotic Crohn’s disease. Hear her story and the misconceptions she’s faced 🎬 ➡️ Read more: loom.ly/QbZj4WU

000

FIBROTARGET @fibrotarget.bsky.social · 16/01/2026

Strictures. Pain. Surgery. What is intestinal fibrosis, and what is FIBROTARGET doing to combat it? Fibrosis in IBD causes scarring, pain & obstruction. No approved treatments exist. FIBROTARGET works on early detection, advanced diagnostics & clinical trials. 🌐Learn more: loom.ly/IGYRLgM

000

FIBROTARGET @fibrotarget.bsky.social · 19/12/2025

🎄 Happy Holidays from the FIBROTARGET project! Thank you for your continued support in advancing research on intestinal fibrosis and fibrostenosis. We wish everyone a restful festive break and look forward to sharing more of our project achievements in 2026🎉. fibrotarget.eu

010

FIBROTARGET @fibrotarget.bsky.social · 02/12/2025

🌟FIBROTARGET Young Talent Spotlight! Meet Lukas Schuster, a PhD student at UK Erlangen studying pathways linked to intestinal fibrosis. He shares his insights and the role of collaboration in driving progress. Learn more here➡️https://loom.ly/ZDwhLh8

020

FIBROTARGET @fibrotarget.bsky.social · 25/11/2025

📥Stay informed on the latest in IBD fibrosis research Sign up for the FIBROTARGET newsletter for project updates, research highlights and upcoming events. Clear, accessible insights for researchers, clinicians, patients and the wider community. Join our growing network!➡️ loom.ly/atbot4M

010

FIBROTARGET @fibrotarget.bsky.social · 14/11/2025

🔍New FIBROTARGET Info Pill! This edition explains biomarkers - measurable signs that help diagnose, monitor and predict IBD activity. By studying these indicators, FIBROTARGET aims to improve fibrosis detection and monitoring for better IBD care. Learn More➡️https://loom.ly/Whlbs78

000

FIBROTARGET @fibrotarget.bsky.social · 30/10/2025

🚨 Last chance! Join the IFCCA Academy’s 2nd online module with FIBROTARGET: 🎥 Living with Fibrosis: Challenges, Treatments & Innovations Learn about the latest in intestinal fibrosis with expert & patient insights. ⏰ Register by 3 Nov: lnkd.in/ebXVwYpR

000

FIBROTARGET @fibrotarget.bsky.social · 27/10/2025

🎤 FIBROTARGET at the 3rd International Workshop on Liver & Gut Fibrosis in Valencia! Earlier this month, Gianluca Matteoli (KU Leuven) & Elena Ricart (Hospital Clínic de Barcelona) presented, joining experts driving forward fibrosis research. Learn more about the event ➡️ loom.ly/Fci-jmY

000

FIBROTARGET @fibrotarget.bsky.social · 07/10/2025

💡FIBROTARGET at #UEGWeek2025! In Berlin, our session “From bench to bedside in fibrosis innovation” gathered KU Leuven, EFCCA, patient advocates & clinicians to discuss advances in IBD fibrosis and next steps towards clinical trials. ➡️Learn more about FIBROTARGET: loom.ly/IGYRLgM

000

FIBROTARGET @fibrotarget.bsky.social · 30/09/2025

🌟 Join us at #UEGWeek 2025 in Berlin! FIBROTARGET partners will be there to discuss the latest in fibrosis innovation and patient-centred trial design. Don’t miss the opportunity to connect and explore how we’re advancing research in intestinal fibrosis! #FIBROTARGET #IBD #FibrosisResearch

000

FIBROTARGET @fibrotarget.bsky.social · 05/09/2025

📣We’re pleased to share that FIBROTARGET will be present at UEG Week 2025 in Berlin! We’ll share progress on advancing research into intestinal fibrosis and fibrostenosis in Crohn’s disease. Stay tuned for details on where to find us! #UEGWeek #FIBROTARGET #CrohnsDisease #IntestinalFibrosis

000

FIBROTARGET @fibrotarget.bsky.social · 27/08/2025

🔍 Interested in the latest advances in intestinal fibrosis research? Stay updated with cutting-edge findings, project news & events by signing up for the FIBROTARGET newsletter. Designed for researchers, clinicians & the wider community. Join here ➡️ loom.ly/atbot4M

000

FIBROTARGET @fibrotarget.bsky.social · 21/08/2025

Looking for reliable information on fibrosis? The FIBROTARGET factsheet is now available in English, Dutch, Spanish, German, French & Italian! Access key insights on IBD-related fibrosis, created with and for the community in partnership with IFCCA! Download your copy 👉 loom.ly/yW8mEBc

011